Malignant pericardial effusion and tamponade

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Pericardial effusion in cancer can reflect direct malignant infiltration, blocked lymphatic drainage, treatment-related inflammation, infection, organ failure or haemorrhage. Lung and breast cancers, lymphoma and melanoma are common malignant associations, but finding cancer and fluid together does not prove tumour in the pericardium. This distinction matters because immune-related pericarditis, tuberculosis, bacterial infection and renal disease require different treatment, while a malignant effusion often signals advanced disease and a substantial recurrence risk.

The clinical danger is tamponade, when pressure in the pericardial sac limits diastolic filling and cardiac output. Rate of accumulation determines tolerance: a chronic malignant effusion may become very large before shock, whereas rapid bleeding after a procedure can cause collapse with far less fluid. Compensatory tachycardia and vasoconstriction can preserve blood pressure until late. Raised venous pressure, pulsus paradoxus, narrow pulse pressure, tachypnoea, cool peripheries and oliguria are more informative than waiting for the complete classic triad.

Urgent transthoracic echocardiography is the key bedside test. It identifies fluid location and depth and looks for right-atrial systolic collapse, right-ventricular early-diastolic collapse, exaggerated respiratory flow variation, inferior vena cava plethora and ventricular interaction. These signs support but do not replace clinical haemodynamics; positive-pressure ventilation, pulmonary hypertension and regional loculation can alter appearances. CT defines tumour, loculation and adjacent thoracic anatomy but must not delay drainage in shock.

Image-guided pericardiocentesis with an indwelling drain is the usual immediate decompression when accessible; surgical drainage is preferred for loculated, purulent, recurrent or technically unsafe collections and when tissue is needed. Drain enough to restore haemodynamics and then control continued removal, watching for decompression syndrome. Fluid cytology, cell count, protein, culture and targeted tuberculosis or molecular studies are chosen from context. Recurrence prevention may involve prolonged drainage, window formation and tumour-directed systemic or radiotherapy, balanced against performance, expected survival and the person's priorities.

Key points

Malignant pericardial fluid results from tumour infiltration or lymphatic obstruction, but infection, treatment inflammation, renal failure, hypothyroidism and bleeding remain competing causes.
Tamponade is a haemodynamic diagnosis: tachycardia, raised JVP, hypotension or narrow pulse pressure, pulsus paradoxus, oliguria and shock matter more than the measured fluid depth alone.
First-line and reference bedside investigation for haemodynamic effect is urgent transthoracic echocardiography, looking for chamber collapse, respiratory inflow variation and a plethoric vena cava in clinical context.
ECG may show low voltage or electrical alternans and chest radiography may show a large silhouette, but neither excludes a rapidly accumulating dangerous effusion.
Unstable tamponade requires immediate image-guided pericardiocentesis with catheter drainage or surgical drainage; pathology staging must not delay decompression.
A cautious small fluid challenge can support preload temporarily while drainage is mobilised, but avoid routine diuresis, nitrates and unnecessary positive-pressure ventilation before decompression.
Send adequate fluid for cytology, microbiology, cell count, protein and other targeted tests; a negative cytology does not fully exclude malignant pericardial disease.
Recurrent, loculated or diagnostic effusion may need a surgical pericardial window, balloon pericardiotomy or tumour-directed therapy aligned with prognosis and patient goals.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Direct malignant involvement

Lung, breast, lymphoma, melanoma and other cancers infiltrate pericardium or obstruct lymphatic drainage, producing exudative and often haemorrhagic fluid.

Cancer treatment injury

Thoracic radiotherapy, immune-checkpoint inflammation and some systemic therapies can cause pericarditis or effusion without direct tumour cells in the fluid.

Infection and immune suppression

Bacterial, tuberculous, viral and fungal pericardial disease can occur during cancer treatment and requires microbiological diagnosis rather than a malignant assumption.

Other coincident causes

Renal failure, hypothyroidism, heart failure, anticoagulant-related bleeding and procedure-related haemopericardium remain relevant in a patient with cancer.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Fluid accumulates under constraint
Secretion, lymphatic obstruction or bleeding expands the pericardial space; tolerance depends on accumulation rate and pericardial compliance more than volume alone.
2
Diastolic filling becomes pressure limited
When intrapericardial pressure reaches chamber filling pressure, right atrial and ventricular filling collapse first and venous pressure rises.
3
Ventricular competition intensifies
Within the fixed sac, inspiratory right-heart filling shifts the septum leftward and reduces left-ventricular stroke volume, producing exaggerated pulsus paradoxus.
4
Cardiac output fails
Compensatory tachycardia and vasoconstriction eventually cannot maintain perfusion, causing obstructive shock, lactic acidosis and pulseless electrical activity.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Compensated tamponade

Tachycardia, dyspnoea, raised JVP and pulsus paradoxus may precede hypotension while vasoconstriction still preserves systolic pressure.

Tamponade shockRed flag

Narrow pulse pressure, cool peripheries, oliguria, confusion, rising lactate or hypotension with pericardial fluid requires urgent drainage.

Rapid haemorrhagic accumulationRed flag

Abrupt pain and collapse after cardiac or thoracic intervention, trauma or anticoagulation suggests haemopericardium that can be lethal at modest volume.

Large chronic effusion

Progressive breathlessness, orthopnoea, chest fullness, cough and reduced exercise tolerance can develop before overt shock in slow malignant accumulation.

Inflammatory phenotype

Pleuritic positional pain, fever, rub and inflammatory markers support pericarditis from treatment, infection or immune disease, but do not exclude simultaneous pressure effect.

Recurrent malignant pattern

Reaccumulation after drainage, haemorrhagic fluid, nodular pericardial imaging or positive cytology supports ongoing tumour or lymphatic obstruction.

Red flags requiring action

Falling blood pressure, narrowing pulse pressure, cool peripheries, oliguria or rising lactate with pericardial fluid indicates tamponade shock.
Severe orthopnoea, tachypnoea, syncope or reduced consciousness requires immediate monitored decompression planning.
A rapid iatrogenic or haemorrhagic collection can cause tamponade at a smaller volume than a slowly accumulating malignant effusion.
Positive-pressure ventilation, anaesthetic induction, nitrate or aggressive diuresis can reduce preload and precipitate collapse before drainage.
Chest pain, hypoxaemia or shock in cancer may instead or additionally reflect pulmonary embolism, acute coronary syndrome, sepsis or tension pneumothorax.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
First-line urgent transthoracic echocardiographyFirst stepFirst line
Why
Confirm pericardial fluid and assess its haemodynamic effect and safe drainage route.
Interpretation and limitations
Integrate chamber collapse, respiratory inflow variation, vena-cava plethora and ventricular interaction with pressure, pulsus and perfusion; no single echo sign defines every case.
02
ECG and continuous rhythm monitoring
Why
Identify tachycardia, low voltage, electrical alternans, ischaemia and arrhythmia before and during drainage.
Interpretation and limitations
Electrical alternans is suggestive but insensitive; a normal-voltage ECG cannot exclude rapid focal or moderate tamponade.
03
FBC, coagulation, renal, liver and lactate
Why
Grade shock, bleeding and organ injury and prepare for drainage and contrast.
Interpretation and limitations
Correct severe procedural coagulopathy where feasible without delaying life-saving decompression; serial lactate and urine output measure recovery.
04
CT chest with contrast when stable
Why
Define tumour, loculated fluid, pleural disease, venous obstruction and alternative thoracic emergencies.
Interpretation and limitations
CT complements echo for anatomy and oncology staging but is non-therapeutic and should not delay pericardial decompression in unstable tamponade.
05
Pericardial fluid analysis
Why
Distinguish malignant, bacterial, tuberculous, inflammatory and haemorrhagic causes.
Interpretation and limitations
Send adequate volume for cytology and targeted microbiology with cell count and chemistry; negative cytology lowers but does not eliminate malignant probability.
06
Pericardial biopsy
Why
Obtain tissue when recurrent or unexplained disease remains clinically important despite non-diagnostic fluid.
Interpretation and limitations
Surgical or image-guided tissue can improve diagnostic yield, particularly for focal thickening; pursue only when the result will change care.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Massive pulmonary embolism

Both cause raised venous pressure and shock; right-ventricular dilatation without pericardial compression and thromboembolic imaging support embolism, which may coexist.

Tension pneumothorax

Unilateral absent breath sounds, hyperresonance and pleural air with mediastinal shift require immediate decompression and should not wait for echocardiography.

Septic or cardiogenic shock

Vasodilatory infection and myocardial failure can produce hypotension and tachycardia; focused ultrasound, perfusion and infection findings determine whether tamponade is causal.

Pleural effusion or airway compression

Large pleural collections and thoracic tumour cause breathlessness but lie outside the pericardium and do not produce characteristic chamber compression.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01UnstableDrain before full stagingFirst stepPericardial fluid accompanies shock, severe dyspnoea, syncope or deteriorating perfusion.

1Use ABCDE, continuous monitoring and immediate focused echo and call cardiology, critical care and the operator able to drain without waiting for elective oncology review.
2Maintain venous return with cautious fluid only when clinically preload-responsive and avoid diuresis, nitrate and avoidable positive-pressure induction that may precipitate collapse.
3Perform urgent image-guided pericardiocentesis with catheter or surgical drainage according to anatomy, operator availability and cause, monitoring haemodynamic recovery continuously.

02Stable effusionDefine cause and significanceA moderate or large effusion is found without current tamponade shock.

1Assess symptoms, pulsus, JVP and serial echo for haemodynamic effect and review cancer, treatment, infection, renal, thyroid, anticoagulant and procedural history.
2Use CT or other staging imaging and decide whether diagnostic drainage, surveillance or tissue is likely to change treatment and recurrence prevention.
3Provide explicit deterioration symptoms and a short review interval because haemodynamics can change between scheduled cancer appointments.

03Diagnostic drainageSample without losing decompression safetyFluid is drained for symptoms, haemodynamics or diagnosis.

1Choose an image-guided route, correct modifiable bleeding risk when time permits and record opening haemodynamics and the amount removed.
2Send sufficient fluid for cytology, culture and targeted studies and leave a catheter when continued drainage reduces early recurrence and procedural repetition.
3Remove the drain only after output and repeat imaging satisfy the local threshold and document pathology ownership and the plan if cytology is negative.

04RecurrenceChoose durable controlEffusion reaccumulates or remains loculated after percutaneous drainage.

1Review systemic cancer options, prognosis, previous cytology and expected burden with cardiology, oncology, surgery and palliative care.
2Offer a surgical window, balloon pericardiotomy or repeat catheter strategy according to loculation, fitness, local expertise and desired durability.
3Treat the underlying tumour or inflammatory or infectious cause and agree whether future recurrence should prompt another procedure or symptom-focused care.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Temporarily supports venous filling and cardiac output before definitive removal of pericardial pressure.

Cautious intravenous crystalloid bridge

When tamponade causes preload-dependent hypotension and pulmonary congestion is absent, give a small monitored isotonic crystalloid bolus while urgent drainage is mobilised, reassessing pressure, lungs and perfusion immediately.

Fluid is a bridge, not treatment; large unmonitored volumes can worsen congestion. Avoid routine diuresis or venodilation before drainage because reducing preload can precipitate collapse.

Treats invasive infection when pus, sepsis or an immunosuppressed presentation suggests a non-malignant infectious cause.

Antibiotic for purulent pericardial disease

If bacterial pericardial infection is suspected, give the local severe-sepsis intravenous regimen immediately after prompt cultures, with renal, allergy and healthcare-exposure adjustment, while arranging surgical or catheter drainage.

Antibiotics cannot sterilise a pressurised purulent collection without drainage. Review cultures daily and consider tuberculosis and fungal disease from epidemiology and immune status.

Reduces ongoing malignant pericardial production in responsive lymphoma, lung, breast and other cancers after immediate haemodynamics are controlled.

Cancer-directed systemic therapy

Use the full histology- and stage-specific oncology regimen after adequate tissue or cytology, with organ-function modification and a documented response-assessment interval.

Systemic therapy is too slow for unstable tamponade and can cause cytopenia, infection or fluid shifts; align treatment burden with prognosis and recurrence-control options.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Obstructive cardiac arrest

Progressive filling failure can culminate in pulseless electrical activity, where immediate drainage accompanies resuscitation and reversible-cause treatment.

Recurrent tamponade

Persistent malignant secretion or lymphatic blockage causes reaccumulation after simple aspiration, especially when no catheter or durable window strategy is used.

Drainage-related injury

Needle or catheter can injure coronary, myocardium, liver or lung and provoke arrhythmia, bleeding, pneumothorax or infection despite imaging guidance.

Pericardial decompression syndrome

Rare ventricular failure and pulmonary oedema can follow rapid drainage of a large chronic effusion, supporting controlled catheter drainage and monitoring.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Before and during drainage, trend pressure, pulse, pulsus when feasible, oxygenation, mental state, urine, lactate and echo haemodynamics.
After drainage, observe rhythm, access site, haemoglobin, respiratory status and ventricular function and investigate pulmonary oedema or new shock for decompression syndrome or injury.
Record catheter output and repeat echo according to the drainage protocol before removal; rising symptoms with falling output may indicate blockage or loculation.
Track cytology, microbiology and any biopsy result with a named owner and reconcile negative fluid with imaging and recurrence pattern.
During tumour treatment, reassess symptoms and effusion at a disease-appropriate interval while avoiding scans that cannot change the plan.
Document the agreed response to future recurrence, including emergency return symptoms, procedural preferences and goals of care.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Rate outranks size

A rapidly bleeding small effusion can cause more dangerous filling pressure than a very large collection accumulated over weeks.

Tamponade is haemodynamic

Echo supports the diagnosis, but shock, venous pressure and perfusion determine urgency rather than a fluid depth threshold alone.

Positive pressure removes compensation

Anaesthetic induction and ventilation reduce venous return and can precipitate arrest in a preload-dependent patient before the sac is drained.

Negative cytology is conditional

Sampling volume, tumour biology and focal infiltration affect sensitivity, so clinical and imaging probability still matters.

Drainage needs an after-plan

A successful tap treats pressure today but not malignant secretion, making catheter duration, window and tumour therapy central to recurrence prevention.

11Common pitfallsFrequent interpretation and management errors.

01
Waiting for hypotension or the full classic triad before recognising tamponade.
02
Using CT staging to delay drainage in a patient with obstructive shock.
03
Giving nitrate or aggressive diuresis to a preload-dependent tamponade patient.
04
Inducing general anaesthesia or positive-pressure ventilation without a decompression and haemodynamic plan.
05
Calling every cancer-associated effusion malignant without testing infection, treatment and organ causes.
06
Accepting one negative cytology as absolute exclusion of pericardial tumour.
07
Removing the catheter without checking output, symptoms and repeat imaging or planning recurrence control.